4. 8) ledsaget af hypotension og bronchospasme er set hos 10% af patienter behandlet med MabThera.
Infusion related adverse reactions including cytokine release syndrome (see section 4.8) accompanied by hypotension and bronchospasm have been observed in 10% of patients treated with MabThera.